Clinical trials
Recruiting Phase 1/2 Cholangiocarcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alentis Therapeutics AG | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Beijing Biotech | 1 |
| Bold Therapeutics, Inc. | 1 |
| DualityBio Inc. | 1 |
| Full-Life Technologies UK Limited | 1 |
| Genfit | 1 |
| Mayo Clinic | 1 |
| ModeX Therapeutics, An OPKO Health Company | 1 |
| National Cancer Institute (NCI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 13 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Bile Duct Neoplasms | 4 |
| Biliary Tract Neoplasms | 4 |
| Colorectal Neoplasms | 4 |
| Endometrial Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Stomach Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Transitional Cell | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.